Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
41M
-
Shares change
-
+80.2K
-
Total reported value, excl. options
-
$1.96B
-
Value change
-
+$8.54M
-
Put/Call ratio
-
0.68
-
Number of buys
-
113
-
Number of sells
-
-78
-
Price
-
$47.70
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q2 2017
240 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q2 2017.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41M shares
of 44.9M outstanding shares and own 91.43% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.48M shares), VANGUARD GROUP INC (3.07M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.06M shares), Partner Fund Management, L.P. (1.84M shares), HealthCor Management, L.P. (1.79M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.22M shares), DARUMA CAPITAL MANAGEMENT LLC (1.12M shares), STATE STREET CORP (1.12M shares), Clearbridge Investments, LLC (1.1M shares), and MACQUARIE GROUP LTD (1.09M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.